Financial Ratios Reliance Industries Ltd
Equities
RELIANCE
INE002A01018
Oil & Gas Refining and Marketing
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,461.80 INR | +0.23% |
|
+1.70% | -6.93% |
| 10/02 | Reliance Industries says Reliance Consumer Products acquires Tamil Nadu's Southern Health Foods | RE |
| 09/02 | Indian Oil, HPCL buy 2 million barrels Venezuelan oil from Trafigura, sources say | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.69 | 3.6 | 4.12 | 4.15 | 3.79 | |||||
Return on Total Capital | 3.58 | 4.55 | 5.49 | 5.74 | 5.29 | |||||
Return On Equity % | 7.63 | 7.7 | 8.58 | 9.01 | 8.4 | |||||
Return on Common Equity | 7.57 | 7.82 | 8.87 | 9.23 | 8.51 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.9 | 32.15 | 32.96 | 35.04 | 34.73 | |||||
SG&A Margin | 3.17 | 2.68 | 2.83 | 2.85 | 2.96 | |||||
EBITDA Margin % | 16.73 | 15.4 | 15.76 | 17.48 | 16.63 | |||||
EBITA Margin % | 11.46 | 11.61 | 11.67 | 12.4 | 11.64 | |||||
EBIT Margin % | 11.46 | 11.61 | 11.67 | 12.4 | 11.64 | |||||
Income From Continuing Operations Margin % | 10.3 | 9.29 | 8.39 | 8.77 | 8.43 | |||||
Net Income Margin % | 10.52 | 8.67 | 7.6 | 7.73 | 7.22 | |||||
Net Avail. For Common Margin % | 9.31 | 8.27 | 7.55 | 7.73 | 7.22 | |||||
Normalized Net Income Margin | 5.69 | 6.25 | 5.87 | 6.24 | 5.7 | |||||
Levered Free Cash Flow Margin | -39.67 | 1.47 | -5.93 | -4.71 | 0.08 | |||||
Unlevered Free Cash Flow Margin | -37.27 | 2.76 | -4.58 | -3.2 | 1.51 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.5 | 0.57 | 0.54 | 0.52 | |||||
Fixed Assets Turnover | 0.92 | 1.28 | 1.4 | 1.25 | 1.2 | |||||
Receivables Turnover (Average Receivables) | 24.15 | 32.82 | 33.71 | 30 | 26.16 | |||||
Inventory Turnover (Average Inventory) | 3.79 | 5.01 | 4.75 | 4 | 4.21 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.34 | 1.12 | 1.07 | 1.18 | 1.1 | |||||
Quick Ratio | 0.9 | 0.58 | 0.57 | 0.62 | 0.6 | |||||
Operating Cash Flow to Current Liabilities | 0.09 | 0.36 | 0.29 | 0.4 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 15.11 | 11.12 | 10.83 | 12.2 | 13.95 | |||||
Days Outstanding Inventory (Average Inventory) | 96.37 | 72.8 | 76.84 | 91.53 | 86.61 | |||||
Average Days Payable Outstanding | 124.14 | 97.7 | 90.12 | 99.61 | 106.97 | |||||
Cash Conversion Cycle (Average Days) | -12.66 | -13.78 | -2.44 | 4.13 | -6.41 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 32.54 | 31.72 | 40.34 | 37.39 | 36.61 | |||||
Total Debt / Total Capital | 24.55 | 24.08 | 28.75 | 27.21 | 26.8 | |||||
LT Debt/Equity | 21.34 | 22.58 | 24.06 | 25.94 | 25.16 | |||||
Long-Term Debt / Total Capital | 16.1 | 17.14 | 17.14 | 18.88 | 18.42 | |||||
Total Liabilities / Total Assets | 39.49 | 40.72 | 48.43 | 47.28 | 48.23 | |||||
EBIT / Interest Expense | 2.99 | 5.63 | 5.41 | 5.13 | 5.08 | |||||
EBITDA / Interest Expense | 4.47 | 7.69 | 7.53 | 7.47 | 7.48 | |||||
(EBITDA - Capex) / Interest Expense | -1.44 | 0.75 | 0.09 | 0.45 | 1.15 | |||||
Total Debt / EBITDA | 3.25 | 2.54 | 2.34 | 2.13 | 2.23 | |||||
Net Debt / EBITDA | 0.86 | 1.13 | 0.95 | 0.8 | 0.85 | |||||
Total Debt / (EBITDA - Capex) | -10.1 | 25.89 | 186.5 | 35.6 | 14.53 | |||||
Net Debt / (EBITDA - Capex) | -2.68 | 11.49 | 75.95 | 13.41 | 5.51 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -21.86 | 49.91 | 26.13 | 2.65 | 7.06 | |||||
Gross Profit, 1 Yr. Growth % | -8.36 | 29.17 | 29.77 | 9.11 | 6.11 | |||||
EBITDA, 1 Yr. Growth % | -12.74 | 34.65 | 26.89 | 10.3 | -1.32 | |||||
EBITA, 1 Yr. Growth % | -20.52 | 51.83 | 29.33 | 9.07 | 0.45 | |||||
EBIT, 1 Yr. Growth % | -20.52 | 51.83 | 29.33 | 9.07 | 0.45 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 8.51 | 35.16 | 16.29 | 7.26 | 2.9 | |||||
Net Income, 1 Yr. Growth % | 24.84 | 23.56 | 9.88 | 4.38 | 0.04 | |||||
Normalized Net Income, 1 Yr. Growth % | -26.07 | 64.77 | 21.1 | 9.19 | -2.13 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -5.14 | 30.1 | 16.46 | 5.03 | 0.04 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.27 | 24.33 | 20.34 | 11.18 | 33.18 | |||||
Inventory, 1 Yr. Growth % | 10.51 | 31.96 | 29.9 | 9.12 | -4.39 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.5 | 8.86 | 20.98 | 10.28 | 12.44 | |||||
Total Assets, 1 Yr. Growth % | 13.32 | 13.51 | 7.19 | 9.24 | 11.06 | |||||
Tangible Book Value, 1 Yr. Growth % | 83.59 | -1.35 | -29.69 | 12.47 | 0.27 | |||||
Common Equity, 1 Yr. Growth % | 55.88 | 11.33 | -8.16 | 10.84 | 6.27 | |||||
Cash From Operations, 1 Yr. Growth % | -72.4 | 310.47 | 3.96 | 38.04 | 12.54 | |||||
Capital Expenditures, 1 Yr. Growth % | 38.32 | -5.38 | 40.78 | 8.44 | -8.45 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -827.39 | -105.34 | -676.55 | -18.45 | -101.78 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -559.46 | -110.63 | -322.83 | -28.26 | -150.5 | |||||
Dividend Per Share, 1 Yr. Growth % | 7.69 | 14.29 | 12.5 | 11.11 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -9.43 | 8.23 | 37.11 | 13.78 | 4.83 | |||||
Gross Profit, 2 Yr. CAGR % | 0.07 | 9.41 | 28.87 | 18.99 | 7.6 | |||||
EBITDA, 2 Yr. CAGR % | -4.41 | 9.75 | 31.43 | 20.19 | 6.01 | |||||
EBITA, 2 Yr. CAGR % | -8.96 | 9.86 | 38.39 | 18.77 | 4.67 | |||||
EBIT, 2 Yr. CAGR % | -8.96 | 9.86 | 38.39 | 18.77 | 4.67 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 9.88 | 21.11 | 23.76 | 11.69 | 5.06 | |||||
Net Income, 2 Yr. CAGR % | 11.4 | 24.2 | 16.52 | 7.09 | 2.18 | |||||
Normalized Net Income, 2 Yr. CAGR % | -12.01 | 10.37 | 39.24 | 14.99 | 3.37 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.17 | 11.09 | 21.31 | 10.6 | 2.5 | |||||
Accounts Receivable, 2 Yr. CAGR % | -20.51 | 9.67 | 22.32 | 15.67 | 21.68 | |||||
Inventory, 2 Yr. CAGR % | 9.95 | 20.76 | 30.93 | 19.06 | 2.14 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.45 | 7.17 | 14.76 | 15.5 | 11.35 | |||||
Total Assets, 2 Yr. CAGR % | 14.81 | 13.41 | 10.3 | 8.21 | 10.14 | |||||
Tangible Book Value, 2 Yr. CAGR % | 45.69 | 34.57 | -16.72 | -11.07 | 6.19 | |||||
Common Equity, 2 Yr. CAGR % | 34.49 | 31.73 | 1.11 | 0.89 | 8.53 | |||||
Cash From Operations, 2 Yr. CAGR % | -21.36 | 7.99 | 106.57 | 19.79 | 24.64 | |||||
Capital Expenditures, 2 Yr. CAGR % | 6.32 | 14.4 | 15.42 | 23.56 | -0.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 49.71 | -36.4 | -48.05 | 116.83 | -87.97 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 54.28 | -28.58 | -52.96 | 26.44 | -39.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.77 | 10.94 | 13.39 | 11.8 | 10.55 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.58 | 7.14 | 13.68 | 24.5 | 11.5 | |||||
Gross Profit, 3 Yr. CAGR % | 11.52 | 9.36 | 15.46 | 21.92 | 14.53 | |||||
EBITDA, 3 Yr. CAGR % | 6.68 | 8.04 | 15.61 | 25.29 | 13.75 | |||||
EBITA, 3 Yr. CAGR % | 3.95 | 7.96 | 15.04 | 27.84 | 12.32 | |||||
EBIT, 3 Yr. CAGR % | 3.95 | 7.96 | 15.04 | 27.84 | 12.32 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.06 | 17.73 | 18.45 | 18 | 8.68 | |||||
Net Income, 3 Yr. CAGR % | 10.84 | 15.32 | 19.23 | 12.32 | 4.69 | |||||
Normalized Net Income, 3 Yr. CAGR % | -4.25 | 8.45 | 12.75 | 28.4 | 8.97 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.02 | 9.04 | 11.76 | 15.62 | 6.96 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.7 | -7.73 | 13.11 | 18.49 | 21.23 | |||||
Inventory, 3 Yr. CAGR % | 10.32 | 16.85 | 23.74 | 23.21 | 10.66 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.69 | 7.92 | 11.59 | 13.25 | 14.47 | |||||
Total Assets, 3 Yr. CAGR % | 17.41 | 14.37 | 11.3 | 9.95 | 9.15 | |||||
Tangible Book Value, 3 Yr. CAGR % | 44.28 | 27.93 | 8.39 | -7.94 | -7.44 | |||||
Common Equity, 3 Yr. CAGR % | 33.62 | 26.28 | 16.81 | 4.26 | 2.65 | |||||
Cash From Operations, 3 Yr. CAGR % | -28.44 | 37.74 | 6.63 | 80.6 | 17.32 | |||||
Capital Expenditures, 3 Yr. CAGR % | 12.69 | 2.27 | 22.6 | 13.04 | 11.81 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 114.03 | -50.05 | 26.94 | -39.62 | -56.3 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 129.69 | -35.83 | 2.04 | -45.85 | -6.88 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.27 | 7.17 | 11.46 | 12.62 | 11.2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.75 | 16.22 | 16.55 | 9.62 | 10.05 | |||||
Gross Profit, 5 Yr. CAGR % | 15.13 | 19.31 | 18.43 | 12.91 | 12.25 | |||||
EBITDA, 5 Yr. CAGR % | 13.58 | 18.24 | 16.54 | 13 | 12.38 | |||||
EBITA, 5 Yr. CAGR % | 12.45 | 18.34 | 16.56 | 11.6 | 10.77 | |||||
EBIT, 5 Yr. CAGR % | 12.45 | 18.34 | 16.56 | 11.6 | 10.77 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10 | 16.86 | 15.35 | 14.68 | 12.9 | |||||
Net Income, 5 Yr. CAGR % | 10.56 | 15.21 | 13.08 | 11.95 | 12.09 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.4 | 11.71 | 11.22 | 10.38 | 8.9 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 5.73 | 11.36 | 9.98 | 9.03 | 7.96 | |||||
Accounts Receivable, 5 Yr. CAGR % | 33.61 | 23.65 | 10.14 | 1 | 16.47 | |||||
Inventory, 5 Yr. CAGR % | 11.93 | 17.1 | 18.14 | 17.72 | 14.6 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.73 | 6.2 | 7.36 | 10.89 | 11.49 | |||||
Total Assets, 5 Yr. CAGR % | 17.14 | 16.05 | 14.51 | 11.87 | 10.84 | |||||
Tangible Book Value, 5 Yr. CAGR % | 30.59 | 27.71 | 15.81 | 10.61 | 7.5 | |||||
Common Equity, 5 Yr. CAGR % | 24.77 | 24.2 | 19.52 | 15.44 | 13.42 | |||||
Cash From Operations, 5 Yr. CAGR % | -7.24 | 17.43 | 9.99 | 30.26 | 13.5 | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.68 | 5.1 | 13.77 | 10.3 | 12.84 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 43.07 | 1.79 | 22.49 | -12.46 | -50.54 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 39.85 | 21 | 22.88 | -16.96 | -17.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.92 | 7.78 | 8.45 | 9 | 11.1 |
- Stock Market
- Equities
- RELIANCE Stock
- Financials Reliance Industries Ltd
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















